PAG
PJP icon

Private Advisor Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Private Advisor Group’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Sell
2,003
-3,874
-66% -$419K ﹤0.01% 2249
2026
Q1 		$610K Buy
+5,877
New +$621K ﹤0.01% 1729
2020
Q3 		– Sell
-2,208
Closed -$143K – 2917
2020
Q2 		$143K Buy
+2,208
New +$137K ﹤0.01% 1514
2019
Q4 		– Sell
-6,107
Closed -$346K – 1719
2019
Q3 		$346K Sell
6,107
-1,407
-19% -$80.9K 0.01% 1228
2019
Q2 		$452K Sell
7,514
-582
-7% -$35.7K 0.01% 1090
2019
Q1 		$528K Buy
+8,096
New +$532K 0.01% 953
2018
Q4 		– Sell
-9,793
Closed -$720K – 1523
2018
Q3 		$720K Buy
9,793
+6,366
+186% +$457K 0.01% 833
2018
Q2 		$232K Sell
3,427
-5,110
-60% -$329K ﹤0.01% 1113
2018
Q1 		$533K Buy
8,537
+4,800
+128% +$316K 0.02% 640
2017
Q4 		$246K Sell
3,737
-10,044
-73% -$644K 0.01% 965
2017
Q3 		$917K Sell
13,781
-1,221
-8% -$77.1K 0.02% 603
2017
Q2 		$939K Buy
15,002
+139
+0.9% +$8.34K 0.03% 562
2017
Q1 		$861K Sell
14,863
-1,913
-11% -$112K 0.02% 585
2016
Q4 		$952K Sell
16,776
-3,929
-19% -$226K 0.03% 513
2016
Q3 		$1.28M Sell
20,705
-662
-3% -$43.4K 0.05% 367
2016
Q2 		$1.39M Sell
21,367
-2,987
-12% -$188K 0.06% 324
2016
Q1 		$1.46M Sell
24,354
-2,052
-8% -$126K 0.07% 278
2015
Q4 		$1.85M Buy
26,406
+525
+2% +$37.2K 0.09% 244
2015
Q3 		$1.72M Sell
25,881
-3,655
-12% -$284K 0.09% 238
2015
Q2 		$2.31M Buy
29,536
+2,914
+11% +$227K 0.11% 189
2015
Q1 		$2.03M Buy
26,622
+3,334
+14% +$245K 0.12% 198
2014
Q4 		$1.55M Buy
23,288
+3,481
+18% +$232K 0.1% 248
2014
Q3 		$1.26M Buy
19,807
+14,871
+301% +$918K 0.09% 260
2014
Q2 		$301K Buy
4,936
+1,150
+30% +$66.7K 0.03% 650
2014
Q1 		$215K Buy
+3,786
New +$215K 0.02% 682

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Private Advisor Group's PJP Position: Q2 2026 in Review

Private Advisor Group reduced its Invesco Pharmaceuticals ETF (PJP) stake by 66% in Q2 2026, selling an estimated $419K and leaving 2,003 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Private Advisor Group first reported a position in PJP in Q1 2014 and has held it in 25 quarters since. The position peaked at $2.31M in Q2 2015. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Private Advisor Group held 2,003 shares of Invesco Pharmaceuticals ETF worth $237K as of Q2 2026.
  • Private Advisor Group sold 3,874 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $419K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2249 holding.
  • Private Advisor Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2014 and has held it in 25 quarters since.
  • Private Advisor Group's Invesco Pharmaceuticals ETF position peaked at $2.31M in Q2 2015.
  • 116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.